Nektar Therapeutics (NKTR) Cash & Equivalents (2010 - 2026)
Nektar Therapeutics (NKTR) posted Cash & Equivalents of $39.27 million for Q2 2026, down 8.7% from $42.99 million a year earlier and down 73.7% from the prior quarter.
Powered by 
Analysis
Nektar Therapeutics (NKTR) Cash & Equivalents (2010 - 2026) Analysis & Trends
At the end of FY2025, Nektar Therapeutics' Cash & Equivalents came in at $15.12 million, down 65.8% from FY2024.
- Annual Cash & Equivalents shows a five-year compound annual growth rate of -40.3% (FY2020 to FY2025).
- In prior years, Nektar Therapeutics' Cash & Equivalents was $44.25 million in FY2024 (+25.4%), $35.28 million in FY2023 (-60.0%), $88.23 million in FY2022 (+249.9%) and $25.22 million in FY2021 (-87.3%).
- Quarterly Cash & Equivalents has run from a low of $15.12 million in Q4 2025 to a high of $149.58 million in Q1 2026 over five years.
- On a year-over-year basis, Cash & Equivalents increased in four of the last eight quarters, with growth averaging 31.5%.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q1 2026, with growth of 284.6%; the weakest was Q4 2021, with a decline of 87.3%.
- According to Business Quant data, Cash & Equivalents for the three prior quarters was $149.58 million (Q1 2026), $15.12 million (Q4 2025) and $41.03 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Nektar Therapeutics | 1.44 Bn | -328.37 Mn | - | 39.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 39.27 Mn |
| Mar 31, 2026 | 149.58 Mn |
| Dec 31, 2025 | 15.12 Mn |
| Sep 30, 2025 | 41.03 Mn |
| Jun 30, 2025 | 42.99 Mn |
| Mar 31, 2025 | 38.89 Mn |
| Dec 31, 2024 | 44.25 Mn |
| Sep 30, 2024 | 30.11 Mn |
| Jun 30, 2024 | 27.94 Mn |
| Mar 31, 2024 | 48.64 Mn |
| Dec 31, 2023 | 35.28 Mn |
| Sep 30, 2023 | 64.92 Mn |
| Jun 30, 2023 | 50.73 Mn |
| Mar 31, 2023 | 76.96 Mn |
| Dec 31, 2022 | 88.23 Mn |
| Sep 30, 2022 | 105.76 Mn |
| Jun 30, 2022 | 77.55 Mn |
| Mar 31, 2022 | 67.99 Mn |
| Dec 31, 2021 | 25.22 Mn |
| Sep 30, 2021 | 54.02 Mn |
API Access
Nektar Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=NKTR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "NKTR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=NKTR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();